phone monitor calendar cart user pin clock hourglass syringe briefcase redo check download camera med-spa plastic-surgery file Lifted Logic Web Design in Kansas City clock location phone play chevron-down chevron-left chevron-right chevron-up facebook facebook-simple checkbox checkbox-checked radio radio-selected instagram google business profile pinterest twitter youtube send linkedin tiktok circle-calendar circle-camera cart email circle-phone circle-pin circle-clock circle-email user phone circle-monitor left-arrow right-arrow chevron-left-thin chevron-right-thin chevron-down-thin chevron-up-thin chevron-down-medium quotes link chevron-right-medium plus remove filter arrow-box trash circle-user cell fax close

Ever wanted a Hand Augmentation? Radiesse Injectable could be the answer!

Radiesse, and injectable filler from Merz Aesthetics, has received approval from the FDA for hand augmentation to eliminate the look of aging due to fat loss/volume loss in the hands. Radiesse can last for up to a year, and provides an immediate volumizing effect that reduces the prominence of tendons and veins in the hands. This new treatment will provide a natural-looking result and make your hands look years younger!

Merz is proud to be able to provide patients and physicians with the first and only dermal filler approved by the FDA for use in the hands,” said Jim Hartman, vice president and head of U.S. Aesthetics/OTC for Merz North America. “Market research tells us that attention to the aesthetic appearance of hands has increased in recent years, particularly among individuals who have undergone facial rejuvenation procedures. This new indication for Radiesse is a result of our focus on meeting unmet needs in the U.S. aesthetics market, and we are excited to provide our physician customers with this new option” says Hartman.

In clinical trials, Radiesse improved the appearance of hands in 75% of treated patients after 3 months. Most adverse events were injection site reactions such as swelling, redness, pain and bruising, which were usually mild to moderate, short in duration (lasting about one week) and require no additional treatment.

Related News